CapsoVision, Inc. (CV) Stock Analysis
A live, multi-source view of CapsoVision, Inc. (CV): real-time price, technical indicators, Wall Street analyst consensus, recent news sentiment and social buzz — aggregated into one place so you can size up the stock at a glance.
About CapsoVision, Inc.
CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon). It also provides CapsoCloud cloud-based software-as-a-service ecosystem as an off-premises video access and download solution; CapsoView, a data access reading device for viewing capsule videos; CapsoAccess, a Capsule data access system; and CapsoRetrieve, a retrieval kit to recover the capsule using a magnetic wand, as well as capsule video reading services. The company serves gastrointestinal medical practices, clinics, and hospitals. It sells its products to distributor customers who resell products. The company was formerly known as Capso Vision Inc. and changed its name to CapsoVision, Inc. in May 2016. CapsoVision, Inc. was incorporated in 2005 and is headquartered in Saratoga, California.
Sector: Healthcare · Industry: Medical Devices · United States · 99 employees · capsovision.com
Key statistics · as of 2026-09-05
As of 2026-09-05, CapsoVision, Inc. (CV) had a market capitalization of $299.8M; the shares traded in a 52-week range of $3.43 – $15.37 (64.0% over the year).
- Market cap
- $299.8M
- Enterprise value
- $291.4M
- Price / book
- 22.78
- EPS (trailing)
- $-1.11
- Payout ratio
- 0.0%
- 52-week range
- $3.43 – $15.37
- 52-week change
- 64.0%
- Average volume
- 141,177
- Shares outstanding
- 50.0M
- Short % of float
- 4.75%
- Profit margin
- -214.7%
Fundamental figures are recorded once every few days, dated above; they are not live and can differ from the interactive tiles.
Last universe scan · 2026-09-11
In RapidTradeView’s 2026-09-11 scan of the US universe, CapsoVision, Inc. (CV) last closed at $6.52 (the last completed close before that scan).
Technicals at the scan: RSI 57 (neutral territory), price +6.7% versus its 20-day average, 20-day versus 50-day average spread -4.8%, MACD histogram 0.08.
Sentiment inputs: StockTwits 78% bullish.
Next scheduled company event: in 62 days from the scan date.
Scan values are recorded once per trading day and are not live quotes; the interactive tiles above update in real time.
Smart Money · last 90 days
Members of Congress disclosed 0 buys and 0 sells of CV; corporate insiders filed 1 buy and 0 sells (1 filer, latest disclosure 2026-07-21). Filings arrive days to weeks after the trade and are not a live signal. Most active filers: Harari Eliyahou Et Al (1B/0S). Who is trading what
RapidTradeView pick record
CV has not appeared in the daily picks yet. Full scoreboard
What this page covers
RapidTradeView pulls CapsoVision, Inc. (CV) data from multiple independent sources and combines it into a single dashboard. Below the summary you’ll find live, interactive tiles for each of the following:
- Price & chart — real-time quote with pre/post-market moves and a line or candlestick chart.
- Technical indicators — RSI, MACD, moving averages, Bollinger Bands, volume and support/resistance, distilled into one overall signal.
- Analyst consensus — the buy/hold/sell breakdown and price targets published by Wall Street analysts.
- News sentiment — recent headlines, each scored for tone so the prevailing narrative is obvious.
- Earnings — current EPS, year-over-year change and the next scheduled earnings date.
- Social buzz — Reddit mention volume and StockTwits sentiment for the retail-trader angle.
How to read the signals
No single indicator tells the whole story. A bullish technical reading paired with a cautious analyst consensus, or strong social buzz against weak earnings, is exactly the kind of tension this view is built to surface. RapidTradeView’s signals are generated by deterministic, statistical models — they describe what the data is doing, they are not personalised recommendations to buy or sell CV.
Disclaimer: RapidTradeView is an educational sentiment-aggregation tool, not a licensed financial adviser, broker, or dealer. Nothing here is financial, investment, tax, or legal advice. Markets are risky and you can lose money. Always do your own research and consult a qualified professional before making any investment decision.